Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development expense	$ 30,960	$ 20,711	$ 52,657	$ 37,634
General and administrative expense	6,241	8,344	13,474	15,767
Total operating expenses	37,201	29,055	66,131	53,401
Loss from operations	(37,201)	(29,055)	(66,131)	(53,401)
Other income (expense):
Interest income	1,460	146	2,940	231
Other income (expense)	(11)	3	(21)	10
Total other income (expense)	1,449	149	2,919	241
Net loss and comprehensive loss	$ (35,752)	$ (28,906)	$ (63,212)	$ (53,160)
Net loss per common share, basic	$ (0.75)	$ (0.77)	$ (1.33)	$ (1.42)
Net loss per common share, diluted	$ (0.75)	$ (0.77)	$ (1.33)	$ (1.42)
Weighted-average shares of common stock outstanding, basic	47,706,426	37,420,327	47,639,977	37,371,614
Weighted-average shares of common stock outstanding, diluted	47,706,426	37,420,327	47,639,977	37,371,614